These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Neoadjuvant endocrine therapy in breast cancer. Beresford MJ; Ravichandran D; Makris A Cancer Treat Rev; 2007 Feb; 33(1):48-57. PubMed ID: 17134840 [TBL] [Abstract][Full Text] [Related]
29. Biomarker changes during neoadjuvant anastrozole, tamoxifen, or the combination: influence of hormonal status and HER-2 in breast cancer--a study from the IMPACT trialists. Dowsett M; Ebbs SR; Dixon JM; Skene A; Griffith C; Boeddinghaus I; Salter J; Detre S; Hills M; Ashley S; Francis S; Walsh G; Smith IE J Clin Oncol; 2005 Apr; 23(11):2477-92. PubMed ID: 15767642 [TBL] [Abstract][Full Text] [Related]
30. Sentinel node biopsy after neoadjuvant treatment in breast cancer: Five-year follow-up of patients with clinically node-negative or node-positive disease before treatment. Galimberti V; Ribeiro Fontana SK; Maisonneuve P; Steccanella F; Vento AR; Intra M; Naninato P; Caldarella P; Iorfida M; Colleoni M; Viale G; Grana CM; Rotmensz N; Luini A Eur J Surg Oncol; 2016 Mar; 42(3):361-8. PubMed ID: 26746091 [TBL] [Abstract][Full Text] [Related]
31. Sentinel lymph node biopsy examination for breast cancer patients with clinically negative axillary lymph nodes after neoadjuvant chemotherapy. Kinoshita T; Takasugi M; Iwamoto E; Akashi-Tanaka S; Fukutomi T; Terui S Am J Surg; 2006 Feb; 191(2):225-9. PubMed ID: 16442950 [TBL] [Abstract][Full Text] [Related]
32. Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation. Gimbergues P; Abrial C; Durando X; Le Bouedec G; Cachin F; Penault-Llorca F; Mouret-Reynier MA; Kwiatkowski F; Maublant J; Tchirkov A; Dauplat J Ann Surg Oncol; 2008 May; 15(5):1316-21. PubMed ID: 18311507 [TBL] [Abstract][Full Text] [Related]
33. Is sentinel lymph node biopsy reliable and indicated after preoperative chemotherapy in patients with breast carcinoma? Haid A; Tausch C; Lang A; Lutz J; Fritzsche H; Peschina W; Breitfellner G; Sega W; Aufschnaiter M; Sturn H; Zimmermann G Cancer; 2001 Sep; 92(5):1080-4. PubMed ID: 11571718 [TBL] [Abstract][Full Text] [Related]
34. Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with cytologically proven node-positive breast cancer at diagnosis. Park S; Park JM; Cho JH; Park HS; Kim SI; Park BW Ann Surg Oncol; 2013 Sep; 20(9):2858-65. PubMed ID: 23645483 [TBL] [Abstract][Full Text] [Related]
35. Sentinel node biopsy after primary chemotherapy in cT2 N0/1 breast cancer patients: Long-term results of a retrospective study. Martelli G; Miceli R; Folli S; Guzzetti E; Chifu C; Maugeri I; Ferranti C; Bianchi G; Capri G; Carcangiu ML; Paolini B; Agresti R; Ferraris C; Piromalli D; Greco M Eur J Surg Oncol; 2017 Nov; 43(11):2012-2020. PubMed ID: 28912071 [TBL] [Abstract][Full Text] [Related]
36. Axillary sentinel lymph node biopsy after neoadjuvant chemotherapy for carcinoma of the breast. Schwartz GF; Tannebaum JE; Jernigan AM; Palazzo JP Cancer; 2010 Mar; 116(5):1243-51. PubMed ID: 20087958 [TBL] [Abstract][Full Text] [Related]
37. Sentinel node biopsy before neoadjuvant chemotherapy spares breast cancer patients axillary lymph node dissection. van Rijk MC; Nieweg OE; Rutgers EJ; Oldenburg HS; Olmos RV; Hoefnagel CA; Kroon BB Ann Surg Oncol; 2006 Apr; 13(4):475-9. PubMed ID: 16485148 [TBL] [Abstract][Full Text] [Related]
38. [Sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer]. Mátrai Z; Tóth L; Polgár C; Láng I; Gõdény M; Sinkovics I; Horváth Z; Bidlek M; Udvarhelyi N; Bartal A; Sávolt A; Ujhelyi M; Kásler M Magy Onkol; 2011 Jun; 55(2):73-84. PubMed ID: 21655472 [TBL] [Abstract][Full Text] [Related]
39. Sentinel lymph node biopsy in patients with multifocal breast cancer. Goyal A; Newcombe RG; Mansel RE; Chetty U; Ell P; Fallowfield L; Kissin M; Sibbering M; Eur J Surg Oncol; 2004 Jun; 30(5):475-9. PubMed ID: 15135472 [TBL] [Abstract][Full Text] [Related]
40. Sentinel Node and Recurrent Breast Cancer (SNARB): results of a nationwide registration study. Maaskant-Braat AJ; Roumen RM; Voogd AC; Pijpers R; Luiten EJ; Rutgers EJ; Nieuwenhuijzen GA Ann Surg Oncol; 2013 Feb; 20(2):620-6. PubMed ID: 22941173 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]